Article
Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular…
BioMed Research International · 2021 · Alessandro Arrigo, author Andrea Saladino, author Emanuela Aragona, author Stefano Mercuri, author Ugo Introini, author Francesco Bandello, author Maurizio Battaglia Parodi, author Teruyo Kida, Academic Editor
Key facts
| Title | Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes |
|---|---|
| First author | Alessandro Arrigo, author Andrea Saladino, author Emanuela Aragona, author Stefano Mercuri, author Ugo Introini, author Francesco Bandello, author Maurizio Battaglia Parodi, author Teruyo Kida, Academic Editor |
| Journal | BioMed Research International |
| Published | Jan 20, 2021 |
| DOI | 10.1155/2021/5516981 |
| Devices mentioned | K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 1 more |
| Product codes mentioned | HOO, OBO, MYC, MXK, HPT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1